A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
Public ClinicalTrials.gov record NCT02157506. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIa Study of the Safety, Tolerability and Hemodynamic Effects of a Continuous 6 Hour Intravenous Infusion of CXL-1427 in Hospitalized Patients With Systolic Heart Failure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A randomized, double-blinded, placebo-controlled study of continuous 6-hour IV infusions of CXL-1427 in hospitalized patients with systolic heart failure.
Study identification
- NCT ID
- NCT02157506
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 70 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 29, 2014
- Primary completion
- May 30, 2015
- Completion
- Jul 30, 2015
- Last update posted
- Jul 30, 2019
2014 – 2015
United States locations
- U.S. sites
- 14
- U.S. states
- 11
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardioxyl Study Site | Gainesville | Florida | 32610 | — |
| Cardioxyl Study Site | Jacksonville | Florida | 32209 | — |
| Cardioxyl Study Site | Jacksonville | Florida | 32224 | — |
| Cardioxyl Study Site | Macon | Georgia | 31201 | — |
| Cardioxyl Study Site | Baltimore | Maryland | 21201 | — |
| Cardioxyl Study Site | Detroit | Michigan | 48202 | — |
| Cardioxyl Study Site | Newark | New Jersey | 07103 | — |
| Cardioxyl Study Site | Chapel Hill | North Carolina | 27517 | — |
| Cardioxyl Study Site | Cincinnati | Ohio | 45267 | — |
| Cardioxyl Study Site | Columbus | Ohio | 43201 | — |
| Cardioxyl Study Site | Charleston | South Carolina | 29425 | — |
| Cardioxyl Study Site | Nashville | Tennessee | 37232 | — |
| Cardioxyl Study Site | Salt Lake City | Utah | 84132 | — |
| Cardioxyl Study Site | Richmond | Virginia | 23298 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02157506, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2019 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02157506 live on ClinicalTrials.gov.